Health Care • Medical/Dental Instruments
$1.00 ▼ -0.10
(-9.09%)
MKT CAP: $4.9M • VOL: 61.2K
52W L $1 52W H $83,600
ROARABLE / RQD
D • 51/100
PIOTROSKI
4 / 9
WOK // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$1.1M | -$3.5M | $112.0K |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.2M | -$2.2M | $2.2M |
| Capital Expenditures (CapEx) | $1.3M | $9.2M | — |
| Free Cash Flow (FCF) | $4.9M | -$11.5M | $2.2M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | — | — | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR WOK.